These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28012778)

  • 1. B cell and antibody responses in mice induced by a putative cell surface peptidase of Pneumocystis murina protect against experimental infection.
    Ruan S; Cai Y; Ramsay AJ; Welsh DA; Norris K; Shellito JE
    Vaccine; 2017 Jan; 35(4):672-679. PubMed ID: 28012778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Immunization of Mice with Live Pneumocystis murina Protects against Pneumocystis Pneumonia.
    Samuelson DR; de la Rua NM; Charles TP; Ruan S; Taylor CM; Blanchard EE; Luo M; Ramsay AJ; Shellito JE; Welsh DA
    J Immunol; 2016 Mar; 196(6):2655-65. PubMed ID: 26864029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal immunization confers protection against murine Pneumocystis carinii lung infection.
    Pascale JM; Shaw MM; Durant PJ; Amador AA; Bartlett MS; Smith JW; Gregory RL; McLaughlin GL
    Infect Immun; 1999 Feb; 67(2):805-9. PubMed ID: 9916094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with Pneumocystis Cross-Reactive Antigen 1 (Pca1) Protects Mice against Pneumocystis Pneumonia and Generates Antibody to Pneumocystis jirovecii.
    Tesini BL; Wright TW; Malone JE; Haidaris CG; Harber M; Sant AJ; Nayak JL; Gigliotti F
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28031260
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunization with Pneumocystis carinii A12
    Tong T; Wang Z; Xu Y; Shen J
    BMC Immunol; 2021 Jun; 22(1):40. PubMed ID: 34174820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell production of tumor necrosis factor in response to Pneumocystis murina infection in mice.
    Opata MM; Ye Z; Hollifield M; Garvy BA
    Infect Immun; 2013 Nov; 81(11):4252-60. PubMed ID: 24002064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumocystis murina colonization in immunocompetent surfactant protein A deficient mice following environmental exposure.
    Linke MJ; Ashbaugh AD; Demland JA; Walzer PD
    Respir Res; 2009 Feb; 10(1):10. PubMed ID: 19228388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant antibody and cellular responses to Pneumocystis major surface glycoprotein variants in mice.
    Bishop LR; Helman D; Kovacs JA
    BMC Immunol; 2012 Jul; 13():39. PubMed ID: 22788748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice.
    Dai G; Noell K; Weckbecker G; Kolls JK
    mSphere; 2021 May; 6(3):. PubMed ID: 33952667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination exposure to zidovudine plus sulfamethoxazole-trimethoprim diminishes B-lymphocyte immune responses to Pneumocystis murina infection in healthy mice.
    Feola DJ; Garvy BA
    Clin Vaccine Immunol; 2006 Feb; 13(2):193-201. PubMed ID: 16467325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with recombinant Pneumocystis carinii p55 antigen provides partial protection against infection: characterization of epitope recognition associated with immunization.
    Smulian AG; Sullivan DW; Theus SA
    Microbes Infect; 2000 Feb; 2(2):127-36. PubMed ID: 10742685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4
    Rapaka RR; Dai G; Zheng M; Kolls JK
    Infect Immun; 2019 Jul; 87(7):. PubMed ID: 31010812
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunization with Pneumocystis carinii gpA is immunogenic but not protective in a mouse model of P. carinii pneumonia.
    Gigliotti F; Wiley JA; Harmsen AG
    Infect Immun; 1998 Jul; 66(7):3179-82. PubMed ID: 9632583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with Recombinant
    Specht CA; Lee CK; Huang H; Hester MM; Liu J; Luckie BA; Torres Santana MA; Mirza Z; Khoshkenar P; Abraham A; Shen ZT; Lodge JK; Akalin A; Homan J; Ostroff GR; Levitz SM
    mBio; 2017 Nov; 8(6):. PubMed ID: 29184017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic and Proteomic Approaches to Finding Novel Diagnostic and Immunogenic Candidates in
    Eddens T; Elsegeiny W; Ricks D; Goodwin M; Horne WT; Zheng M; Kolls JK
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31484742
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccine-Induced Immunogenicity and Protection Against Pneumocystis Pneumonia in a Nonhuman Primate Model of HIV and Pneumocystis Coinfection.
    Kling HM; Norris KA
    J Infect Dis; 2016 May; 213(10):1586-95. PubMed ID: 26823337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of p57, a Stage-Specific Antigen of Pneumocystis murina.
    Bishop LR; Davis AS; Bradshaw K; Gamez M; Cisse OH; Wang H; Ma L; Kovacs JA
    J Infect Dis; 2018 Jun; 218(2):282-290. PubMed ID: 29471356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid phage displaying SLAQVKYTSASSI induces protection against Candida albicans challenge in BALB/c mice.
    Wang Y; Su Q; Dong S; Shi H; Gao X; Wang L
    Hum Vaccin Immunother; 2014; 10(4):1057-63. PubMed ID: 24448202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ T cell-independent vaccination against Pneumocystis carinii in mice.
    Zheng M; Shellito JE; Marrero L; Zhong Q; Julian S; Ye P; Wallace V; Schwarzenberger P; Kolls JK
    J Clin Invest; 2001 Nov; 108(10):1469-74. PubMed ID: 11714738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic p55 tandem DNA vaccine against Pneumocystis carinii in rats.
    Fan H; Guo JY; Ma SL; Zhang N; An CL
    Microbiol Immunol; 2016 Jun; 60(6):397-406. PubMed ID: 27185490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.